1. Home
  2. WHR vs KOD Comparison

WHR vs KOD Comparison

Compare WHR & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whirlpool Corporation

WHR

Whirlpool Corporation

HOLD

Current Price

$40.26

Market Cap

2.7B

ML Signal

HOLD

Logo Kodiak Sciences Inc

KOD

Kodiak Sciences Inc

HOLD

Current Price

$39.66

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHR
KOD
Founded
1911
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
WHR
KOD
Price
$40.26
$39.66
Analyst Decision
Hold
Buy
Analyst Count
9
7
Target Price
$74.33
$35.43
AVG Volume (30 Days)
2.3M
541.5K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
6.59%
N/A
EPS Growth
196.42
N/A
EPS
N/A
N/A
Revenue
$21,253,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.58
N/A
52 Week Low
$35.45
$8.29
52 Week High
$96.46
$47.84

Technical Indicators

Market Signals
Indicator
WHR
KOD
Relative Strength Index (RSI) 47.39 47.05
Support Level $38.51 $38.72
Resistance Level $45.74 $46.29
Average True Range (ATR) 2.00 2.79
MACD -0.29 -0.48
Stochastic Oscillator 14.83 37.45

Price Performance

Historical Comparison
WHR
KOD

About WHR Whirlpool Corporation

Whirlpool Corp is a manufacturer and marketer of kitchen and laundry appliances, with its presence in different markets around the world. It offers products like refrigerators, washing machines, cooktops, ovens, freezers, and others, which are marketed through various brands such as KitchenAid, Maytag, Amana, Brastemp, Consul, Whirlpool, Jennair, etc. The company's operating and reportable segments are: Major Domestic Appliances (MDA) North America (its key revenue-generating segment), MDA Europe, MDA Latin America, and Small Domestic Appliances (SDA) Global.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Share on Social Networks: